MORGAN STANLEY PLC/CALL/ZOETIS/260/0.1/20.06.25 | Market Closed - Börse Stuttgart 09:28:50 28/05/2024 BST | ||
| 0.37 EUR | 0.00% |
|
| Current month | +5.71% | ||
| 1 month | +15.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
| Date | Price | Change |
|---|---|---|
| 28/05/24 | 0.37 | 0.00% |
| 27/05/24 | 0.37 | -7.50% |
| 24/05/24 | 0.4 | 0.00% |
| 23/05/24 | 0.4 | 0.00% |
| 22/05/24 | 0.4 | -2.44% |
Delayed Quote Börse Stuttgart
Last update May 28, 2024 at 09:28 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ZOETIS INC. |
| Issuer | Morgan Stanley |
| WKN | MB5NJC |
| ISIN | DE000MB5NJC1 |
| Date issued | 17/04/2023 |
| Strike | 260 $ |
| Maturity | 20/06/2025 (388 Days) |
| Parity | 10 : 1 |
| Emission price | 0.9 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.53 € |
|---|---|
| Lowest since issue | 0.23 € |
| Spread | 0.01 € |
| Spread % | 2.56% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
171.3
USD
Average target price
211.2
USD
Spread / Average Target
+23.29%
- Stock Market
- Warrants
- Warrant
